Cyclerion Therapeutics CYCN Q4 2025 Earnings Narrower Loss Surprises Analysts ASBA Q1 2026 Earnings Subordinated Notes Benefit from EPS Beat as Associated BancCorp Reports Solid Quarter GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development Catalyst Bancorp Inc CLST Q3 2025 Earnings Modest Profitability Amid Quiet Quarter MT Q1 2026 Earnings Modest EPS Beat Amid Revenue Uncertainty ARQ Q1 2026 Earnings NarrowerthanExpected Loss Amid Operational Discipline